Addressing the Burden of Allergic Rhinitis: Advancing Care to Improve Patient Outcomes Webcast

Faculty Presenter

Rohit K. Katial, MD
Program Director
Allergy and Immunology
National Jewish Health
Professor of Medicine
Department of Medicine
National Jewish Health
University of Colorado Health Sciences Center
Denver, Colorado

Co-sponsored by:

NJH new


Supported by an
educational grant from:

TR 2


Minimum System Requirements

Windows XP, Windows 2000, Windows Vista, and Windows 7 Intel Pentium 4, 2.33 + GHz (or equivalent)
Adobe® Flash® Player 10

Mac OS X v10.4 or later
1.8GHz or faster (or equivalent)
Intel Core Duo 1.33GHz or faster (or equivalent)
Adobe® Flash® Player 10

Click here for more information on minimum system requirements.

Privacy Policy

When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and...(continued)

Release date: February 28, 2013
Expiration date: February 28, 2014
Estimated time to complete activity: 1.0 hour

Program Overview

Allergic rhinitis is one of the most common conditions seen in practice and has a substantial impact on a patient's quality of life. It is important that clinicians are able to make an appropriate diagnosis and formulate treatment plans that are concordant with available clinical guidelines for the management of patients with allergic rhinitis. Further, there is need for clinicians to recognize all of the available therapeutic options in order to develop treatment plans that consider individual patient preferences, thereby improving adherence. 

This program will discuss these important issues and review available clinical guidelines for the management of patients with allergic rhinitis. Interactive patient video testionials that demonstrate clinically relevant examples of patients with allergic rhinitis will be incorporated to provide an opportunity for a detailed discussion of best practices for patient management.

    Target Audience

    This activity has been designed to meet the educational needs of otolaryngologists, allergists, primary care physicians, nurse practitioners, physician assistants, and other healthcare providers involved in the treatment of patients with allergic rhinitis.

    Learning Objectives

    Upon completion of this educational activity, participants should be able to:
          • Recognize and differentiate allergic rhinitis symptoms from other common upper respiratory conditions
          • Formulate management plans for patients with allergic rhinitis according to available evidence-based clinical guidelines
          • Describe the characteristics of available therapeutic options for patients with allergic rhinitis
          • Implement strategies to improve treatment adherence while considering patient preference for therapy

              Accreditation Statement

              National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

              Credit Designation

              National Jewish Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

              Disclosure of Conflicts of Interest

              All faculty in a position to control the content of this activity are expected to disclose any or no significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

              Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (eg, stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. For the purposes of CME accreditation National Jewish Health considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

              All CME Educational Activities sponsored by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation by our faculty CME committee. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

              Sean Gregory, PhD, Esther Langmack, MD, and David Tinkleman, MD hereby state that they or their spouses/life partners do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity or any amount during the last 12 months.

              Rohit K. Katial, MD
              Advisory Board/Consultant: Teva

              Directions to the Learner

              There are no fees for participating and receiving CME credit for this activity. During the period of February 28, 2013, through February 28, 2014, participants must:

              • Read the learning objectives and faculty disclosure
              • Complete the pretest
              • Study the educational activity
              • Complete the posttest and evaluation form

              A statement of credit will be issued only upon receipt of a completed posttest with a score of 70% or better and a completed evaluation form. Your statement of credit will be mailed to you within 4 weeks.



              National Jewish Health

              For questions about the accreditation of this activity, please contact National Jewish Health at 800-844-2305 or visit

              Disclosure of Unlabeled Use

              This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. National Jewish Health, Integrity Continuing Education, Inc., and TEVA Respiratory do not recommend the use of any agent outside of the labeled indications.

              The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of National Jewish Health, Integrity Continuing Education, Inc., and TEVA Respiratory. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


              The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgement of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

              begin pretest